-

Iron Path Capital Closes Fund I, Exceeds Target at $273 Million

CHARLOTTESVILLE, Va. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Iron Path Capital (“Iron Path” or “IPC”), an operationally focused private equity firm investing in the specialty industrials and healthcare sectors, today announced the final closing of Iron Path Capital Fund I (“Fund I”), exceeding the $250 million target with total commitments of $273 million. The Fund I limited partners consist of a diverse group of global investors including leading endowments, fund of funds, institutional investors and family offices.

“We are extremely grateful for the investors that have decided to partner with us in our inaugural institutional fund,” said Iron Path Managing Partner and Co-founder Rob Reistetter. “This marks an important achievement for the firm and is a reflection of our differentiated capabilities and the strong team that we have built over our first three years.”

Iron Path Capital targets control investments in lower-middle market specialty industrial and healthcare companies, in partnership with founders and managers, to build and grow great businesses. Iron Path focuses on sectors where the firm has deep expertise and where they can create transformational outcomes with the operational resources of the Full Immersion Operations team (“FIOps™”).

“Our approach includes developing an investment thesis and partnering with founders and managers to scale businesses organically and with strategic acquisitions,” said Scott Mraz, fellow co-founder and Managing Partner. “We have curated a team of limited partners, strategic advisors and Iron Path professionals who share our unique vision and our steadfast values.”

M2O Private Fund Advisors acted as the exclusive placement agent. Foley & Lardner LLP served as fund counsel.

About Iron Path Capital

Iron Path Capital is an operationally focused private equity firm focused on lower-middle-market investments across the healthcare and specialty industrial sectors. With offices in Nashville, TN and Charlottesville, VA, Iron Path Capital supports its partners with capital, operating expertise, business development, and industry relationships to achieve significant scale. Iron Path Capital selects companies with stable cash flows, superior management teams, strong performance trajectories, and multiple vectors for growth, both organic and through consolidation.

For more information, visit ironpathcapital.com.

Contacts

Iron Path Capital Contact:
Rob Reistetter, Managing Partner
Media@ironpathcapital.com

Iron Path Capital

Details
Headquarters: Nashville & Charlottsville, Tennessee & Virginia
CEO: Rob Reistetter
Employees: 8
Organization: PRI

Release Versions

Contacts

Iron Path Capital Contact:
Rob Reistetter, Managing Partner
Media@ironpathcapital.com

Social Media Profiles
More News From Iron Path Capital

Iron Path Capital Welcomes Ian Thomas as Managing Director – Head of Business Development

NASHVILLE, Tenn.--(BUSINESS WIRE)--Iron Path Capital (Iron Path), a private equity firm focused on healthcare and specialty industrials, today announced the appointment of Ian Thomas as Managing Director – Head of Business Development to lead origination and business development for the firm and its portfolio companies. His experience in both private equity and investment banking provides a wide expertise to drive Iron Path’s strategic growth and value-add capabilities. “Ian’s track record make...

Iron Path Capital Names Jake Fitzgerald as New CEO of PureTech Scientific

NASHVILLE, Tenn. & BELLE, W. Va.--(BUSINESS WIRE)--Iron Path Capital (Iron Path), a private equity firm focused on healthcare and specialty industrials, today announced the appointment of industry veteran Jake Fitzgerald as Chief Executive Officer of PureTech Scientific LLC (PureTech), a global leader in glycolic acid synthesis and technology. PureTech was founded by Iron Path after acquiring the Glycolic Acid business from The Chemours Company last August. Fitzgerald most recently served as Pr...

Capitol Pain Institute Acquires Pain Care Surgery of Louisville

NASHVILLE, Tenn. & LOUISVILLE, Ky.--(BUSINESS WIRE)--Iron Path Capital, a private equity firm focused on building differentiated businesses in the healthcare and specialty industrials sectors, is pleased to announce that Capitol Pain Institute (CPI) has acquired the ambulatory surgical center (ASC) Pain Care Surgery of Louisville. This strategic move allows CPI to offer more advanced procedures, including spinal cord and peripheral nerve stimulation, interspinous stabilization and fixation, and...
Back to Newsroom